Shares of medical equipment maker Mettler-Toledo International (MTD) surged 5.14% in the pre-market Friday, after the company provided an upbeat annual profit forecast for 2025.
Mettler-Toledo expects its adjusted profit per share for the full year 2025 to be between $42.35 and $43.00, exceeding analysts' average estimate of $42.13. The company cited strong demand for its laboratory instruments used in drug development as a key driver behind the bullish profit outlook.
The positive annual forecast comes on the heels of Mettler-Toledo's better-than-expected fourth quarter performance. For the period ended December 31st, the company reported an adjusted profit of $12.41 per share, beating Wall Street's consensus estimate of $11.71 per share. Quarterly sales also topped expectations, rising 12% year-over-year to $1.05 billion.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。